Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo
Author(s) -
Michał Abram,
Marcin Jakubiec,
Katelyn Reeb,
Mary Hongying Cheng,
Robin Gedschold,
Anna Rapacz,
Szczepan Mogilski,
Katarzyna Socała,
Dorota Nieoczym,
Małgorzata Szafarz,
Gniewomir Latacz,
Bartłomiej Szulczyk,
Justyna KalinowskaTłuścik,
Kinga Gaweł,
Camila V. Esguerra,
Elżbieta Wyska,
Christa E. Müller,
İvet Bahar,
Andréia C. K. Fontana,
Piotr Właź,
Rafał M. Kamiński,
Krzysztof Kamiński
Publication year - 2022
Publication title -
journal of medicinal chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.01
H-Index - 261
eISSN - 1520-4804
pISSN - 0022-2623
DOI - 10.1021/acs.jmedchem.2c00534
Subject(s) - chemistry , pharmacology , pentylenetetrazol , in vivo , allosteric modulator , allosteric regulation , adme , pharmacokinetics , in vitro , drug , epilepsy , biochemistry , anticonvulsant , receptor , biology , neuroscience , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom